MYDA Advisors LLC acquired a new position in Karuna Therapeutics, Inc. ( NASDAQ:KRTX – Free Report ) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 8,000 shares of the company's stock, valued at approximately $1,453,000. Several other institutional investors and hedge funds have also added to or reduced their stakes in KRTX. Almanack Investment Partners LLC. bought a new stake in Karuna Therapeutics during the third quarter worth about $51,000.

https://www.dailypolitical.com/2023/09/09/myda-advisors-llc-purchases-new-shares-in-karuna-therapeutics-inc-nasdaqkrtx.html

#dailypolitical